{"id":"W2954966588","doi":"10.1200/jco.2019.37.15_suppl.8018","title":"Patient-reported outcomes (PROs) with ibrutinib-rituximab in Waldenström macroglobulinemia (WM): Results from iNNOVATE.","year":2019,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre; Royal Victoria Regional Health Centre; Ottawa Hospital; Royal Victoria Hospital; University of Ottawa","funders":"","keywords":"Medicine; Rituximab; Ibrutinib; Anemia; Internal medicine; Placebo; Visual analogue scale; Waldenstrom macroglobulinemia; Quality of life (healthcare); Refractory (planetary science); Randomized controlled trial; Gastroenterology; Surgery; Lymphoma; Leukemia; Chronic lymphocytic leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005427996,0.0006932261,0.001281955,0.0005371277,0.0001753313,0.0006950321,0.0008049859,0.001027765,0.001626407],"category_scores_gemma":[0.002939638,0.0002600771,0.00291318,0.0006779081,0.0005486803,0.0006709919,0.0006942641,0.001431533,0.0002898086],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008180739,"about_ca_system_score_gemma":0.0004891807,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006776746,"about_ca_topic_score_gemma":0.001281621,"domain_scores_codex":[0.9981549,0.0009581861,0.0001352291,0.0002255034,0.0003551793,0.0001710389],"domain_scores_gemma":[0.9973308,0.0006895843,0.001288551,0.000130902,0.0002085585,0.0003516421],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.7542361,0.006976254,0.05755262,0.002334763,0.009942507,0.000112317,0.0002634893,0.001772215,0.004926122,0.0002538284,0.004097981,0.1575319],"study_design_scores_gemma":[0.3295067,0.2084532,0.4265128,0.0007120263,0.01842856,0.000569621,0.000214772,0.002890942,0.002888906,0.0004639283,0.009245245,0.0001133685],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9718756,0.02139966,0.0002709649,0.0004600645,0.00005700402,0.000527667,0.003277286,0.00003335639,0.002098436],"genre_scores_gemma":[0.9885821,0.004475047,0.0009363178,0.0007127307,0.0001858395,0.0006895411,0.003821971,0.00001176047,0.0005845915],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005427996,"threshold_uncertainty_score":0.02870637,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07737395609271454,"score_gpt":0.4418125535232706,"score_spread":0.3644385974305561,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}